Impact of connecting continuous renal replacement therapy to the extracorporeal membrane oxygenation circuit

被引:16
|
作者
De Tymowski, Christian [1 ,2 ,3 ,6 ]
Desmard, Mathieu [1 ,2 ]
Lortat-Jacob, Brice [1 ,2 ]
Pellenc, Quentin [4 ]
Alkhoder, Soleiman [5 ]
Alouache, Arezki [1 ,2 ]
Fritz, Benedicte [1 ,2 ]
Montravers, Philippe [1 ,2 ,3 ,7 ]
Augustin, Pascal [1 ,2 ]
机构
[1] Grp Hosp Bichat Claude Bernard, AP HP, Dept Anaesthesiol, HUPNVS, F-75018 Paris, France
[2] Grp Hosp Bichat Claude Bernard, AP HP, Surg Intens Care Unit, HUPNVS, F-75018 Paris, France
[3] Paris Diderot Sorbonne Cite Univ, Paris, France
[4] HUPNVS, AP HP, Dept Thorac & Vasc Surg, F-75018 Paris, France
[5] HUPNVS, AP HP, Dept Cardiovasc Surg, Paris, France
[6] Paris Diderot Paris 7, Inserm UMR 1149, Fac Med, Ctr Rech Inflammat, Site Bichat,16 Rue Henri Huchard, F-75018 Paris, France
[7] Inserm UMR 1152, Physiopathol & Epidemiol Malad Resp, Fac Bichat, 16 Rue Henri Huchard, F-75018 Paris, France
关键词
CWH; ECMO; Dialysis catheter; Circuit life; Circuit clotting; Blood flow; CONTINUOUS VENOVENOUS HEMOFILTRATION; CRITICALLY-ILL PATIENTS; HEPARIN ANTICOAGULATION; REGIONAL CITRATE; VASCULAR ACCESS; LIFE; PERFORMANCE; FAILURE; ADULTS;
D O I
10.1016/j.accpm.2018.02.024
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose: Continuous veno-venous haemofiltration (CVVH) directly connected to extracorporeal membrane oxygenation (ECMO) may ensure better blood flow and allow prolonged circuit life. The objective of this study was to assess circuit life of CVVH connected to ECMO and to a dialysis catheter. Materials and methods: In this prospective observational study, patients receiving CWH via ECMO were compared to time-matched patients receiving CVVH via a conventional dialysis catheter. CVVH circuit life and the safety and efficacy of the two CVVH procedures were analysed. Time to event was estimated using Kaplan-Meier analysis and compared using the log-rank test. Results: Seventeen patients were included in each group, with 43 sessions in the ECMO group and 56 sessions in the DC group. Median CWH circuit life was 48 [21-72] vs 20 [6-39] hours in the ECMO and DC groups, respectively (relative risk of termination of the session: 2.4, 95% CI [1.41-3.9], log rank P= 0.0009). CWH blood flow was higher in the ECMO group. Despite higher anticoagulant doses in the catheter group, the circuit clotting rate was lower in the ECMO group. Effluent volume was slightly higher in the ECMO group (39 ml/kg/h [33-47] vs 34 ml/kg/h [32-39]), but with no biological impact. CVVH via ECMO was well tolerated with no major drawbacks. Conclusions: In patients requiring ECMO, CVVH connected to ECMO instead of DC could be proposed as an alternative approach, allowing more stable blood flow and prolonged CVVH circuit life. (C) 2018 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:557 / 564
页数:8
相关论文
共 50 条
  • [21] Renal replacement therapy during extracorporeal membrane oxygenation
    Balasubramanian Subbarayan
    Vadamalai Vivek
    Madhan Kumar Kuppuswamy
    Indian Journal of Thoracic and Cardiovascular Surgery, 2021, 37 : 261 - 266
  • [22] Renal replacement therapy during extracorporeal membrane oxygenation
    Subbarayan, Balasubramanian
    Vivek, Vadamalai
    Kuppuswamy, Madhan Kumar
    INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 37 (SUPPL 2) : 261 - 266
  • [24] EFFECT OF EARLY CONTINUOUS RENAL REPLACEMENT THERAPY WITH EXTRACORPOREAL MEMBRANE OXYGENATION ON NEONATAL NUTRITION
    Murphy, H.
    Cahill, J.
    Kiger, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 613 - 613
  • [25] Continuous renal replacement therapy in neonates and young infants during extracorporeal membrane oxygenation
    Cavagnaro, F.
    Kattan, J.
    Godoy, L.
    Gonzalez, A.
    Vogel, A.
    Rodriguez, J. I.
    Faunes, M.
    Fajardo, C.
    Becker, P.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2007, 30 (03): : 220 - 226
  • [26] Meropenem Disposition in Neonatal and Pediatric Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
    Pokorna, Pavla
    Michalickova, Danica
    Tibboel, Dick
    Berner, Jonas
    ANTIBIOTICS-BASEL, 2024, 13 (05):
  • [27] Prognostic factors in patients treated with extracorporeal membrane oxygenation and continuous renal replacement therapy
    Hiramatsu, Toshiki
    Shimizu, Shigemitsu
    Koga, Hidenobu
    PERFUSION-UK, 2022, 37 (06): : 570 - 574
  • [28] Timing for initiation of sequential continuous renal replacement therapy in patients on extracorporeal membrane oxygenation
    Paek, Jin Hyuk
    Park, Seohyun
    Lee, Anna
    Park, Seokwoo
    Chin, Ho Jun
    Na, Ki Young
    Lee, Hajeong
    Park, Jung Tak
    Kim, Sejoong
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2018, 37 (03) : 239 - 247
  • [29] Extracorporeal membrane oxygenation combined with continuous renal replacement therapy in patients with circulatory failure
    Song, Yanyan
    Ma, Fuzheng
    Ma, Mengying
    Yang, Jian
    ASIAN JOURNAL OF SURGERY, 2023, 46 (11) : 4875 - 4876
  • [30] Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how?
    Ostermann, Marlies
    Connor, Michael, Jr.
    Kashani, Kianoush
    CURRENT OPINION IN CRITICAL CARE, 2018, 24 (06) : 493 - 503